vimarsana.com

Latest Breaking News On - Pharmaxis ltd - Page 3 : vimarsana.com

Global Inhalable Drugs Industry Trends and Competitive

Pharmaxis finalises sale of MBU to Arna Pharma; shifts focus to blood-related cancer treatments

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has completed the sale of its mannitol respiratory business (MBU) to Arna Pharma Pty Ltd. On October 3, 2023, PXS.

The morning catch up: ASX set to fall after day of market bloodletting in US and EU

FIVE at FIVE AU: ASX down 1 5% on Middle East fears; employment slows

Australia’s benchmark index ended the session down 1.5% as local investors followed Wall Street s lead overnight on worries about rising Middle East.

Pharmaxis to focus on clinical-stage drug development

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips tells Proactive the company is set to undergo a restructure to refocus on developing drugs to treat.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.